Fox Chase Cancer Center News

PHILADELPHIA (May 28, 2021)—Scientists at Fox Chase Cancer Center have provided new insight into how viruses spread through the central nervous system and how they can live on in these parts of the body long after a person appears to have recovered from disease.

PHILADELPHIA (May 28, 2021)—Scientists at Fox Chase Cancer Center have provided new insight into how viruses spread through the central nervous system and how they can live on in these parts of the body long after a person appears to have recovered from disease.

PHILADELPHIA (May 27, 2021)—The Bladder Cancer Advocacy Network (BCAN) has recognized Benjamin Miron, MD, a medical oncology fellow at Fox Chase Cancer Center, with the 2021 New Discoveries Young Investigator Award.

PHILADELPHIA (May 26, 2021)—Although there have been treatment advances over the years, multiple myeloma is still an incurable disease. It is characterized by periods of remission and relapse resulting in decreased survival outcomes following initial therapies. But now, Fox Chase Cancer Center is one of a handful of hospitals in the country to offer patients a new treatment option.

PHILADELPHIA (May 24, 2021)—Mary B. Daly, MD, PhD, FACP, professor in the Department of Clinical Genetics and director of the Risk Assessment Program at Fox Chase Cancer Center, recently received the National Comprehensive Cancer Network’s (NCCN) Rodger Winn Award.

PHILADELPHIA (May 19, 2021)—In a study released today, researchers at Fox Chase Cancer Center and a team of international researchers identified a mutated gene called LRRK2 that may indicate a predisposition to malignant mesothelioma.  

PHILADELPHIA (May 18, 2021)—Data from a new study by researchers at Fox Chase Cancer show that avapritinib, a platelet-derived growth factor receptor A (PDGFRA) inhibitor, has a “clinically meaningful benefit” for the treatment of gastrointestinal stromal tumors (GIST) with PDGFRA D842V mutations.

PHILADELPHIA (May 18, 2021) – In a study posted today, researchers at Fox Chase Cancer Center announced that they have discovered a new factor contributing to early lung cancer formation.